NCT03526861 · Interventional trial
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Overall registry status Completed
Phase 3
Conditions Atopic Dermatitis
Delaware Valley sites
- LEO Pharma Investigational Site · East Windsor, NJ · Mercer County
- LEO Pharma Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory